Abstract-Broadband ultrasonic attenuation (BUA) is a clinically-accepted measurement for prediction of osteoporotic fracture risk. Typical clinical BUA measurements are performed with phase-sensitive receivers and, therefore, can be affected by phase cancellation. In order to separate the effects of conventional attenuation (absorption plus scattering) from phase cancellation, BUA was measured on phantoms with acrylic wedge phase aberrators and on 73 women using both phase sensitive (PS) and phase insensitive (PI) reception. A clinical bone sonometer with a twodimensional (2-D) receiver array was used. PI BUA measurements on phantoms with acrylic wedge phase aberrators were found to be far more resistant to phase cancellation than PS BUA measurements. In data from 73 women, means and standard deviations for BUA measurements were 81.4 21.4 dB/MHz (PS) and 67.2 9.7 dB/MHz (PI). The magnitude of the discrepancy between PS BUA and PI BUA tended to increase with bone mineral density (BMD).
I. Introduction
Q uantitative ultrasound (QUS) is now a wellestablished modality for osteoporotic fracture risk assessment [1] , [2] . Broadband ultrasonic attenuation (BUA) and speed of sound (SOS) reflect bone mineral density (BMD) [3] - [15] and mechanical properties [8] , [9] , [12] , [16] , both of which are related to fracture risk. Calcaneal BUA (sometimes combined with SOS) has been demonstrated to be predictive of osteoporotic fractures in women in prospective [17] - [24] and retrospective [25] - [32] studies. Anisotropy studies suggest that BUA, unlike BMD, is sensitive not only to the quantity of bone intercepting the ultrasound beam but also the physical arrangement (i.e. microarchitecture) of the bone [33] - [35] . QUS is less expensive, faster, simpler, and more portable than its x-ray counterparts: dual-energy x-ray absorptiometry (DEXA) and quantitative computed tomography (QCT). Unlike x-ray methods, QUS produces no ionizing radiation. A recently-developed, handheld, through-transmission, calcaneal ultrasound system appears to represent a significant advance in portability compared with current commercial ultrasound devices [36] . Despite recent progress in QUS, improvements are needed in order to foster greater clinical acceptance [37] . BUA usually is measured using two broadband transducers in a through-transmission geometry around the calcaneus. Most studies listed above report that attenuation exhibits an approximately linear dependence on frequency in the diagnostic frequency range (about 300-700 kHz). Two studies have confirmed quasilinearity up to about 2 MHz [38] , [39] .
Ultrasonic attenuation measurements can be affected by phase cancellation [40] - [45] . Phase cancellation reduces the amplitude of the attenuated signal and, therefore, tends to lead to overestimation of conventional attenuation (absorption plus scattering). Phase cancellation usually increases with frequency and, therefore, also tends to lead to increased attenuation slope. Phase cancellation can be suppressed using so-called phase-insensitive (PI) processing [40] - [43] . PI processing is impossible with singleelement, phase-sensitive (PS) receivers but possible with arrays (see Section II).
Petley et al. [44] were the first to systematically investigate the effect of phase cancellation on BUA estimates in human calcaneus. They compared PS and PI estimates of BUA on 10 normal volunteers. They transmitted with a single cycle of 400 kHz ultrasound and received with a small aperture (5-mm diameter) 5 MHz resonant ceramic transducer that was scanned in order to sweep out an area equal to that of the transmitter (25-mm diameter circle). They found that PS measurements of BUA were, on the average, higher than PI measurements by 31.2 dB/MHz. Strelitzki et al. [45] , however, compared PS and PI measurements of BUA on 10 calcanea in vitro (with soft tissue removed) using a 3 × 3 receiver array and found a much smaller difference, with PS BUA only about 4.3 dB/MHz greater than PI BUA.
Langton et al. [8] , [46] investigated the role of phase cancellation due to uneven propagation paths through cortical plates on BUA. They measured BUA in calcaneus samples in vitro with and without cortical plates present and found an average increase of about 7 dB/MHz due to cortical plates. They pointed out that this difference could not be explained by absorption alone as "a cortex of 1-mm thickness would only provide a BUA of approximately 0.1 dB/MHz." They then showed, using computer simulation and experimental measurements on Perspex plates, that the 7 dB/MHz difference could be explained by phase cancellation artifacts produced by curved interfaces. Xia et al. [47] developed a theoretical model and performed experiments on 18 cadaver calcanea to show that corti-cal plates have a significant effect on BUA. Eddin et al. [48] reported a phase-aberration correction that they implemented in a bone sonometer that used two-dimensional (2-D) arrays (24 × 24) for both transmission and reception of ultrasound through the calcaneus.
In this paper, a clinical study to further probe the effect of phase cancellation on BUA measurements is presented. The present study has advantages over previous ones. Compared with the 5-mm receiving transducers used by Petley et al. [44] and Strelitzki et al. [45] , the approximately 2-mm array elements used in the present study provided better spatial resolution for measurement of the attenuated ultrasound field. Unlike the in vitro study by Strelitzki et al. [45] , the present study was conducted in vivo. Compared with the 9-element array used by Strelitzki et al. [45] , the 52-element receiver array used in the present study provided finer sampling in order to more closely approximate a typical single-element, phase-sensitive receiver. Although the previous investigations used nonimaging data acquisition systems, the present study was aided by real-time attenuation imaging, which facilitated accurate and reproducible positioning of the calcaneus. The present study was based on a larger number of measurements in bone (73 versus 10 by Petley et al. [44] and Strelitzki et al. [45] ), resulting in lower standard errors of estimates of mean values. The present study is the first to investigate the dependence of phase-cancellation artifact on BMD. The present study is the first to measure phase-cancellation artifact with a commercial clinical bone sonometer.
II. Methods

A. Ultrasonic Data Acquisition and Analysis
An Achilles Insight clinical bone sonometer (General Electric Lunar Corp., Madison, WI) was used. This system uses a circular (25.4-mm diameter) broadband piston transducer (center frequency = 500 kHz) for transmission of ultrasound into the heel. Radiofrequency (RF) data were acquired using 52 central elements of the Insight's 590 element 2-D receiver array. The central 52 elements were roughly bounded by a circle that was co-axial with the transmitter. The element spacing was 3.175 mm. The element size was about 2 mm. The beam propagation distance was 10 cm. Data were digitized at 10 MHz. The achilles insight displays a real-time attenuation image in order to permit accurate positioning of the foot prior to data acquisition.
PS power spectra were obtained by summing timedomain RF signals from the central 52 elements of the 2-D receiver array, and taking the squared modulus of the fast Fourier transform (FFT). PI power spectra were obtained by computing the magnitude of the FFT for each of the 52 time-domain RF signals, summing the 52 FFT magnitudes, and squaring.
A calibration spectrum was obtained by performing a measurement with only a water path between the trans- mitting and receiving transducers. BUA was computed from the slope of a least-squares regression to the log spectral difference between calibration and data spectra. The analysis bandwidth was from 240 kHz to 600 kHz. Often in biomedical ultrasound, this slope is normalized to the thickness of the sample to yield "attenuation slope" or nBUA (normalized BUA). This usually is not done in clinical bone sonometry, however, because the bone thickness usually is unknown. (However, a recent system that performs two-sided, pulse-echo interrogation has been reported to accurately measure calcaneal thickness in vivo [49] .) Thicker bones tend to have less fracture risk, so it can be useful for a diagnostic measurement to convey bone thickness information in addition to bone material properties. (Similarly, BMD is an areal rather than a volumetric measurement, measured in grams/centimeter 2 rather than grams/centimeter 3 .) Therefore, BUA generally is reported in units of decibels/megahertz rather than decibels/centimeter/megahertz. Fig. 1 shows the experimental setup for phantom measurements. An ultrasound bone phantom (General Electric, Madison, WI), with values of BUA and SOS mimicking human calcaneus, was placed in a miniature water tank between the transmitter and receiver of the achilles insight. In order to produce phase cancellation, an acrylic wedge also was placed in the acoustic path. Because the speed of sound in acrylic (2727 m/s) is much faster than that in water (1480 m/s), acoustic energy passing through thicker portions of the wedge arrived at the receiver sooner than acoustic energy passing through thinner portions. Five different wedges, with deflection angles of 0
B. Phantom Measurements
• , 1.5
• , and 6
• , were used (see Fig. 2 ). The wedge thickness at the beam midpoint was the same for all five wedges. Therefore, the bulk amount of acrylic intercepted by the propagating ultrasound beam (and the total amount of attenua- tion) was the same for all five wedges. Seven independent transmission measurements (with repositioning) were performed for each wedge.
Excess attenuation was characterized by ∆nBUA = nBUA − nBUA PI,0 where nBUA PI,0 was the value measured using PI processing on the data acquired from the θ = 0
• wedge. In a second set of phantom experiments, water in the tank was replaced with isopropyl alcohol. The speed of sound in isopropyl alcohol (1170 m/s) created a bigger sound speed mismatch with acrylic than water, exacerbating phase cancellation artifacts. Again, seven independent transmission measurements (with repositioning) were performed for each wedge.
C. Simulation
Wedge experiments were simulated using MATLAB (The MathWorks Inc., Natick, MA). The effect of a wedge was modeled by introducing a linear phase shift across the lateral dimension of the receiver array. The phase shift was ∆φ(x) = (k 2 − k 1 )x tan θ where k = 2π/λ, λ is the ultrasonic wavelength, x is the lateral position across the array, θ is the deflection angle of the wedge, and subscripts 1 and 2 indicate properties for the fluid (water or alcohol) and the wedge (acrylic), respectively. The phase shift was applied to digitized measurements of signals measured experimentally with only the phantom and the fluid present. The wedge angle could be continuously adjusted, which allowed interpolation between and extrapolation beyond, experimental measurements at θ = 0
• , 4.5 • , and 6
• .
D. Clinical Protocol
The GE Lunar Achilles Insight was used to measure BUA in the nondominant feet of 73 ambulatory, nonpregnant women who were free of conditions that may be associated with altered bone metabolism, including chronic renal disease, chronic liver disease, hyperparathyroidism, ) and also as a T-score (the number of standard deviations above or below the mean value for the normal reference population). The World Health Organization stratifies subjects as follows: T > −1 (normal), −2.5 < T < −1 (osteopenia or low bone density), and T < −2.5 (osteoporosis) (see http://www.nof.org/osteoporosis/bmdtest.htm). Some experts have expressed concern regarding application of these thresholds, originally derived from axial skeletal data, to peripheral sites such as calcaneus [50] - [52] . However, in the absence of a widely-accepted alternative, they remain the clinical standard for calcaneal measurements and at least serve as a useful approximate method to stratify subjects.
III. Results
Figs. 3 and 4 show PS and PI spectra with and without a bone-mimicking phantom and an acrylic wedge in the water path. In the absence of an aberrating medium, the two spectra were nearly identical (Fig. 3) . In the presence of an aberrating medium (wedge), the PS spectrum was substantially lower than the PI spectrum (Fig. 4) . Fig. 5 shows PS and PI estimates of excess nBUA as functions of wedge deflection angle (θ) for acrylic wedges immersed in water. The PI measurements showed far less variation with θ and, therefore, were a much more reliable indicator of the bulk quantity of acrylic intercepting the ultrasound beam (which was constant for all wedges). The simulation accurately predicted the dependences of excess nBUA on θ for both PS and PI cases. Fig. 6 shows PS and PI estimates of excess nBUA as functions of wedge deflection angle (θ) for acrylic wedges immersed in alcohol. The same trends that were observed for water occurred with alcohol. The values of excess nBUA were greater, however, because the mismatch in sound speed between the fluid and the acrylic was greater than in the previous case. Fig. 7 shows the 2-D array of pulses transmitted through the calcaneus of a volunteer. The heterogeneity of the calcaneus is apparent. Fig. 8 shows PS and PI spectra of pulses transmitted through the calcaneus of a volunteer. As was seen with the acrylic wedges, the PS spectrum is markedly lower than the PI spectrum, particularly at high frequencies. Fig. 9 shows average attenuation versus frequency for the 73 women. The means and standard deviations for BUA measurements were 81.4 ± 21.4 dB/MHz (PS) and 67.2 ± 9.7 dB/MHz (PI). Therefore, conventional PS processing overestimated true BUA by about 14.2 dB/MHz. Fig. 11 shows the difference between PS BUA and PI BUA for the 73 women. It can be seen that the range of the discrepancy between the two tended to increase with BMD. The level of scatter in Figs. 10 and 11 may be due, in part, to imperfect coregistration of ultrasonic and x-ray regions of interest. Fig. 12 shows a scatter plot of PS BUA and PI BUA measurements on the 73 women. The correlation coefficient between the two measurements was r = 0.71 (95% CI: 0.57 − 0.81). Fig. 13 shows a scatter plot of data in the format used in Bland Altman analysis [53] : BUA differential (PS BUA −PI BUA) versus mean BUA ((PS BUA + PI BUA)/2). 
IV. Discussion
This paper describes the first comparison of PS BUA and PI BUA measured with clinical bone sonometer hardware. It also describes the first investigation into the effect of BMD on the discrepancy between the two. The superior resistance to phase cancellation of PI BUA was confirmed using acrylic wedge phase aberrators. The number of subjects measured in this study exceeded numbers from previous studies by a factor of seven. In data from 73 women, means and standard deviations for BUA measurements were 81.4 ± 21.4 dB/MHz (PS) and 67.2 ± 9.7 dB/MHz (PI). The range of discrepancies between PS BUA and PI BUA tended to increase dramatically with BMD (see Fig. 11 ). PS BUA is the standard upon which current clinical QUS fracture-risk data is based. Therefore, it is not inappropriate that commercial bone sonometers measure PS BUA rather than PI BUA. The point of this investigation was to analyze the relative contribution of conventional attenuation (i.e., absorption plus scattering) as opposed to phase cancellation in determining PS BUA. A greater understanding of these physical processes that underlie the clinical BUA measurements may lead to improvements in future bone sonometry technology.
The discrepancy between PS BUA and PI BUA in the present study, 14.2 dB/MHz, is less than that reported in the seminal paper by Petley et al. [44] tion artifacts on average if their subjects tended to have bigger calcanea and, therefore, perhaps more potential for phase cancellation. As shown in Fig. 11 , the magnitude of the discrepancy between PS BUA and PI BUA in the present study tended to increase with BMD. Although the present study investigated normal, osteopenic and osteoporotic women, the study of Petley et al. [44] investigated five normal men and five normal women. Another source of disparity between the two studies is the receiver element size (2 mm in the present study versus 5 mm in the study of Petley et al.) . A smaller element size would be expected to result in more accurate sampling of the local ultrasonic field. The present study had the benefit of real-time attenuation imaging, which may have enabled more accurate positioning of feet prior to data acquisition. Unfortunately, real-time calcaneal attenuation imaging systems were not available at the time of Petley et al.'s study.
The discrepancy between PS BUA and PI BUA in the present study, 14.2 dB/MHz, is more than that reported by Strelitzki et al. [45] , 4.3 dB/MHz. Strelitzki et al. performed measurements on calcanea from human cadavers. Although Strelitzki et al. did not report demographic statistics, it is possible that the bones were taken from relatively old subjects with low BMD, which might lead to a comparatively small discrepancy between PS BUA and PI BUA (again, see Fig. 11 ). In addition, Strelitzki et al. removed all soft tissues from their specimens, which also likely would tend to reduce phase cancellation artifacts.
The tendency for phase-sensitive receivers to produce overestimates of attenuation has ramifications with respect to investigations of backscatter from calcaneus. Previous studies have reported backscatter coefficients from human calcaneus in vitro between 0.01 to 0.1 cm −1 Sr −1 for frequencies between 300 kHz and 1 MHz [54] , [55] . These studies found that average calcaneal backscatter coefficient was approximately proportional to frequency to the n th power with values for n in the range of 3 to 3.5. In order to estimate backscatter coefficient, it is necessary to compensate measurements of frequency-dependent backscatter with assumed frequency-dependent attenuation coefficients, which in these studies was measured with phasesensitive transducers. Overestimation of magnitude and frequency dependence of attenuation coefficient would result in overestimation of magnitude and frequency dependence (e.g., power law exponent) of backscatter coefficient. These studies investigated purely trabecular bone samples in water and, therefore, were exempt from the aberrating effects of skin, muscle, fat, marrow, and lateral cortical plates that contributed in the present clinical study. Therefore, the magnitude of the overestimation of backscatter coefficient and power-law exponent in in vitro studies remains unclear. This issue warrants further investigation.
V. Conclusions
It has been shown here that phase cancellation effects are significant in conventional (phase-sensitive) BUA, and they can be mitigated by using phase-insensitive detection. Whether phase-insensitive detection can outperform phase-sensitive detection for fracture-risk prediction (the principal clinical task), however, remains to be seen.
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